Craig R. Rayner - 02 Sep 2021 Form 4 Insider Report for Certara, Inc. (CERT)

Role
PRESIDENT, INTEGRATED DRUG DEV
Signature
/s/ Richard M. Traynor, Attorney-in Fact for Craig R. Raynor
Issuer symbol
CERT
Transactions as of
02 Sep 2021
Net transactions value
-$1,978,664
Form type
4
Filing time
07 Sep 2021, 17:16:33 UTC
Previous filing
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERT Common Stock Sale $130,689 -3,900 -1.1% $33.51 366,572 02 Sep 2021 Direct F1, F2
transaction CERT Common Stock Sale $64,885 -1,900 -0.52% $34.15 364,672 02 Sep 2021 Direct F3, F4
transaction CERT Common Stock Sale $1,775,648 -48,462 -13% $36.64 316,210 02 Sep 2021 Direct F5, F6
transaction CERT Common Stock Sale $7,442 -200 -0.06% $37.21 316,010 02 Sep 2021 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $32.91 to $33.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F4 This transaction was executed in multiple trades at prices ranging from $34.12 to $34.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F6 This transaction was executed in multiple trades at prices ranging from $36.19 to $37.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F8 This transaction was executed in multiple trades at prices ranging from $37.21 to $37.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.